Heartland Group (HGH) H1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2026 earnings summary
15 Jun, 2026Executive summary
Net profit after tax (NPAT) for 1H2026 was $48.8 million, with underlying NPAT at $46.1 million, marking a strong turnaround from the prior period and significant year-over-year improvement.
Underlying return on equity (ROE) rose 540 basis points to 7.3%, with average net interest margin (NIM) expanding 51 basis points to 3.92%.
Asset quality improved, with impairment expense ratio dropping to 0.35% and cost-to-income (CTI) ratio reduced by 304 basis points to 54.6%.
Strategic reset and technology investments, along with NSA realisation, drove improvements across all key metrics.
Interim dividend declared at 3.5 cents per share, up 1.5 cps from 1H2025, with a payout ratio of 72%.
Financial highlights
Net interest income increased to $165.9 million, up 11.3% year-over-year, and net operating income rose by $15.4 million.
Operating expenses decreased to $94.4 million, while underlying operating expenses rose 4% due to Australian growth and technology investments.
Underlying EPS was 4.9 cps, up 4.5 cps year-over-year.
Aggregate receivables grew, with strong growth in reverse mortgages and livestock finance in both NZ and AU.
Impairment expense fell 74.7% to $12.8 million, with sharp reduction in non-performing loans.
Outlook and guidance
FY2026 guidance reaffirmed: underlying NPAT of at least $85 million and ROE of at least 7%.
NIM expected to remain above 3.90% group-wide, with NZ banking NIM above 4.10% and AU banking above 3.70%.
Underlying OPEX guidance now provided at group and segment level, with CTI ratio targets below 56% for both banks.
Impairment expense ratios expected to remain low: NZ below 0.70%, AU below 0.10%.
Regulatory capital requirements for the banking group will be reduced effective 1 March 2026.
Latest events from Heartland Group
- $620M merger forms NZ's seventh largest bank, targeting $34M synergies and EPS growth by 2026.HGH
M&A announcement24 Jun 2026 - Underlying NPAT fell 4.9% below guidance, but strategic growth and digitalisation drive outlook.HGH
H2 202415 Jun 2026 - Profit dropped on higher impairments, but reverse mortgage growth and NIM expansion continue.HGH
H1 202515 Jun 2026 - FY2025 underlying NPAT met guidance; FY2026 targets $85m+ NPAT and 7%+ ROE.HGH
H2 202515 Jun 2026 - Impairment expenses surged amid rising arrears and defaults, with tough conditions expected to continue.HGH
Investor presentation14 May 2026 - FY2025 underlying NPAT set to exceed $45m, with strong growth and improved asset quality.HGH
Investor presentation14 May 2026 - Strategic reset, financial rebound, and digital focus drive growth and efficiency.HGH
AGM 202513 Nov 2025 - Lower profit but strong receivables growth and strategic transformation set the FY2028 path.HGH
AGM 202413 Jun 2025